Manufacturer Provide Pharmaceutical Antitumor Erlotinib HCl Powder CAS 183319-69-9 Erlotinib Hydrochloride

Introduction

Product Name: Erlotinib hydrochloride 

Other Name :RLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT

CAS NO:183319-69-9

Purity: 99%min
Appearance:White crystalline powder

Molecular formula:C22H24ClN3O4

MW:429.9

Melting Pint :223-225°C

Storage :Keep in dark place,Inert atmosphere,Room temperature

Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined as a first-line treatment for locally advanced and metastatic pancreatic cancer.